Episode details
Available for over a year
Genetically engineered immune cells had a success rate of more than 90%. Professor John Gribben is Chair of Medical Oncology at Barts hospital in London. (Photo: A close up image of a lung x-ray of a cigarette smoker in an undated photo. Credit: Getty Images.)
Programme Website